Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
NetEase ADR | NTES | 2. avr 2025 | 106.40 | +0.05 |
Netflix | NFLX | 2. avr 2025 | 935.52 | +0.77 |
NETGEAR | NTGR | 2. avr 2025 | 24.90 | -0.08 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | 2. avr 2025 | 46.87 | +0.36 |
NetScout Systems | NTCT | 2. avr 2025 | 21.57 | +1.27 |
NETSOL Technologies | NTWK | 2. avr 2025 | 2.48 | +2.48 |
Netstreit | NTST | 2. avr 2025 | 15.69 | -0.63 |
Network-1 Technologies | NTIP | 2. avr 2025 | 1.29 | -0.91 |
Neuberger Berman | NML | 2. avr 2025 | 9.19 | -0.05 |
Neuberger Berman High Yield Strategies Fund | NHS | 2. avr 2025 | 7.67 | +0.20 |
Neuberger Berman Municipal Fund | NBH | 2. avr 2025 | 10.48 | +0.29 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | 2. avr 2025 | 12.47 | +0.89 |
Neuberger Berman Real Estate Securities Income Fund | NRO | 2. avr 2025 | 3.30 | +0.15 |
NeueHealth | NEUE | 2. avr 2025 | 6.60 | 0.00 |
Neumora Therapeutics | NMRA | 2. avr 2025 | 0.94 | +2.97 |
Neuphoria Therapeutics | NEUP | 2. avr 2025 | 5.80 | 0.00 |
Neuraxis | NRXS | 2. avr 2025 | 2.15 | +1.90 |
Neurocrine Biosciences | NBIX | 2. avr 2025 | 108.31 | +1.22 |
Neurogene | NGNE | 2. avr 2025 | 10.46 | +8.34 |
NeuroMetrix | NURO | 2. avr 2025 | 4.42 | +0.23 |
Neuronetics | STIM | 2. avr 2025 | 3.94 | +4.23 |
NeuroOne | NMTC | 2. avr 2025 | 0.86 | -1.12 |
Neuropace | NPCE | 2. avr 2025 | 13.54 | +3.28 |
NeuroSense Therapeutics | NRSN | 2. avr 2025 | 0.92 | +1.08 |
Nevro | NVRO | 2. avr 2025 | 5.84 | 0.00 |
New Century Logistics (BVI) Limited - Ordinary Shares | NCEW | 2. avr 2025 | 1.80 | +7.14 |
New Concept Energy | GBR | 2. avr 2025 | 0.73 | -6.79 |
New England Realty Associates LP Unit A | NEN | 2. avr 2025 | 79.50 | -0.56 |
New Era Helium | NEHC | 2. avr 2025 | 1.07 | -0.93 |
New Fortress Energy A | NFE | 2. avr 2025 | 8.57 | +13.06 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.